Sign up to save your podcasts
Or
Share E55: Anifrolumab for SLE (TULIP 1&2)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E55: Anifrolumab for SLE (TULIP 1&2)
This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE. Great to see a new drug in this disease state; interesting to think through how these trials played out. Get the papers and the pod at ebrheum.com and follow me @ebrheum if you'd like to share feedback!
View all episodes
By Michael Putman
4.9
111111 ratings
This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE. Great to see a new drug in this disease state; interesting to think through how these trials played out. Get the papers and the pod at ebrheum.com and follow me @ebrheum if you'd like to share feedback!
More shows like The Evidence Based Rheumatology Podcast
View all
JAMA Clinical Reviews
496 Listeners
Rheumnow Podcast
118 Listeners
The Curbsiders Internal Medicine Podcast
3,321 Listeners
Core IM | Internal Medicine Podcast
1,081 Listeners
Healio Rheuminations
119 Listeners
The Clinical Problem Solvers
514 Listeners
ACR on Air
67 Listeners
Around the Rheum
5 Listeners
Rheumatology For The Royal College
171 Listeners
RheumMadness Podcast
11 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
Talking Rheumatology Research
1 Listeners
Talking Rheumatology
0 Listeners
Talking Rheumatology Spotlight
5 Listeners
ACR Journals On Air
18 Listeners